YmAbs Therapeutics (YMAB)
(Delayed Data from NSDQ)
$16.26 USD
-0.24 (-1.45%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $16.30 +0.04 (0.25%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, YmAbs Therapeutics (YMAB) reported earnings of -$0.02 per share, beating the Zacks Consensus Estimate of $-0.19 per share. This reflects a positive earnings surprise of 89.47%. Look out for YMAB's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year increase of 20%.
Earnings History
Price & Consensus
Zacks News for YMAB
YmAbs Therapeutics (YMAB) Surges 8.2%: Is This an Indication of Further Gains?
YMAB: What are Zacks experts saying now?
Zacks Private Portfolio Services